| Identification of the site of inhibition of oncogenic ras-p21-induced signal transduction by a peptide from a ras effector domain. | None |
| Oncogenic Ras induces p19ARF and growth arrest in mouse embryo fibroblasts lacking p21Cip1 and p27Kip1 without activating cyclin D-dependent kinases. | None |
| An oncogenic epidermal growth factor receptor signals via a p21-activated kinase-caldesmon-myosin phosphotyrosine complex. | None |
| Brd2 protein participates in a nuclear complex that contains E2Fs. Overexpression of Brd2 protein with oncogenic ras transactivates E2F-dependent promoters of the cell cycle regulatory genes dihydrofolate reductase, cyclin D1, cyclin A and cyclin E. | None |
| Gene-modified spontaneous Epstein-Barr virus-transformed lymphoblastoid cell lines as autologous cancer vaccines: mutated p21 ras oncogene as a model. | None |
| K-ras codon 12 mutation induces higher level of resistance to apoptosis and predisposition to anchorage-independent growth than codon 13 mutation or proto-oncogene overexpression. | None |
| Interferon-gamma protects astrocytes from apoptosis and increases the formation of p21ras-GTP complex through ras oncogene family overexpression. | None |
| Plasmid expression of a peptide that selectively blocks oncogenic ras-p21-induced oocyte maturation. | None |
| Differences in patterns of activation of MAP kinases induced by oncogenic ras-p21 and insulin in oocytes. | None |
| Oncogenic levels of mitogen-activated protein kinase (MAPK) signaling of the dinucleotide KRAS2 mutations G12F and GG12-13VC. | None |
| oncogenic levels of mitogen-activated protein kinase (MAPK) signaling of the dinucleotide KRAS2 mutations G12F and GG12-13VC | None |
| [Expression of oncogene ras product p21 protein in the tissues of penis cancer and its surrounding tissues]. | None |
| Oncogenic ras induces premature senescence in endothelial cells: role of p21(Cip1/Waf1). | None |
| p21ras Oncogene Protein Selectively Increases Low-voltage-activated Ca2+ Current Density in Embryonic Chick Dorsal Root Ganglion Neurons. | None |
| Targeted expression of oncogenic K-ras in intestinal epithelium causes spontaneous tumorigenesis in mice. | None |
| Comparison of the average structures, from molecular dynamics, of complexes of GTPase activating protein (GAP) with oncogenic and wild-type ras-p21: identification of potential effector domains. | None |
| K-ras oncogene DNA sequences in pink salmon in streams impacted by the Exxon Valdez oil spill: no evidence of oil-induced heritable mutations. | None |
| Development of a simple and sensitive technique for detection of point mutations in the K-ras oncogene. | None |
| Identification of p21WAF1/CIP1 as a direct target of EWS-Fli1 oncogenic fusion protein. | None |
| Direct identification of all oncogenic mutants in KRAS exon 1 by cycling temperature capillary electrophoresis. | None |